1.A Case of Retroperitoneal Fibrosis with Regression by Steroid Therapy.
Seung Yeup HAN ; Choong Hwan KWAK ; Hyun Chul KIM ; Chun Il KIM
Korean Journal of Medicine 2005;68(6):717-718
No abstract available.
Retroperitoneal Fibrosis*
2.A Case of Retroperitoneal Fibrosis Treated with Longitudinal Ureteromyotomy Successfully.
Jun Mo KIM ; Young Ho KIM ; Yoon Soon JEON ; Nam Kyu LEE
Korean Journal of Urology 2000;41(9):1151-1153
No abstract available.
Retroperitoneal Fibrosis*
3.Retroperitoneal Fibrosis Associated with Immunoglobulin G4-related Disease.
Jang Won CHOI ; Jin Myung PARK
The Korean Journal of Gastroenterology 2017;70(2):107-110
No abstract available.
Immunoglobulins*
;
Retroperitoneal Fibrosis*
4.Idiopathic Retroperitoneal Fibrosis Treated with High Dose Steroids.
Hyun Woo KIM ; Wang Jin PARK ; Su Yeon CHO
Korean Journal of Nephrology 2005;24(6):1017-1021
Idiopathic retroperitoneal fibrosis is proliferation of fibrous tissue with inflammatory process due to unknown etiology, that may involve the ureters and other retroperitoneal structures. The majority of reported cases have been treated surgically by ureterolysis or intraperitonealization of the ureters. Recently, successful management of retroperitoneal fibrosis by administration of steroids also has been reported. We report two cases of patients who underwent successful treatment of an idiopathic retroperitoneal fibrosis with high dose steroids therapy.
Humans
;
Retroperitoneal Fibrosis*
;
Steroids*
;
Ureter
;
Ureteral Obstruction
5.A case of retroperitoneal fibrosis.
Xiang-Shan XU ; Yuan-Zhe JIN ; Qi WANG
Chinese Journal of Cardiology 2009;37(11):1047-1048
6.A Case of Marked Hydroureter, Misdiagnosed as a Hydrosalpinx by Ultrasound.
Mi La KIM ; Yun Hee KO ; Yeon Jean CHO ; Jun Gil PAEK ; Hyuk Jun WOO ; Jun Sik HONG ; Jun Hyung CHO ; Kwan Young JOO
Korean Journal of Obstetrics and Gynecology 2004;47(2):388-393
The retroperitoneal space of the posterior abdomen and the pelvic retroperitoneum contain the major neural, vascular and lymphatic supply to the pelvic viscera, the urinary system and colorectal system. A pain or mass in the pelvis may arise primarily from the reproductive organs, but it may just as easily arise from the retroperitoneal space, include the urinary tract and the gastrointestinal tract. Therefore, the gynecologic surgeon should be aware of the various conditions associated with retroperitoneal mass and the correct management of these disorders. Hydroureter may misdiagnose as a pelvic mass or retroperitoneal mass. The cause of hydroureter is mainly secondary obstruction such as malignancy, idiopathic retroperitoneal fibrosis and pelvic disease but primary obstructive megaureter should be considered. This report describes a case of marked hydroureter, misdiagnosed as a hydrosalpinx by ultrasound.
Abdomen
;
Gastrointestinal Tract
;
Pelvis
;
Retroperitoneal Fibrosis
;
Retroperitoneal Space
;
Ultrasonography*
;
Urinary Tract
;
Viscera
7.A Case of Marked Hydroureter, Misdiagnosed as a Hydrosalpinx by Ultrasound.
Mi La KIM ; Yun Hee KO ; Yeon Jean CHO ; Jun Gil PAEK ; Hyuk Jun WOO ; Jun Sik HONG ; Jun Hyung CHO ; Kwan Young JOO
Korean Journal of Obstetrics and Gynecology 2004;47(2):388-393
The retroperitoneal space of the posterior abdomen and the pelvic retroperitoneum contain the major neural, vascular and lymphatic supply to the pelvic viscera, the urinary system and colorectal system. A pain or mass in the pelvis may arise primarily from the reproductive organs, but it may just as easily arise from the retroperitoneal space, include the urinary tract and the gastrointestinal tract. Therefore, the gynecologic surgeon should be aware of the various conditions associated with retroperitoneal mass and the correct management of these disorders. Hydroureter may misdiagnose as a pelvic mass or retroperitoneal mass. The cause of hydroureter is mainly secondary obstruction such as malignancy, idiopathic retroperitoneal fibrosis and pelvic disease but primary obstructive megaureter should be considered. This report describes a case of marked hydroureter, misdiagnosed as a hydrosalpinx by ultrasound.
Abdomen
;
Gastrointestinal Tract
;
Pelvis
;
Retroperitoneal Fibrosis
;
Retroperitoneal Space
;
Ultrasonography*
;
Urinary Tract
;
Viscera
8.Idiopathic Retroperitoneal Fibrosis Treated with Medical Therapy.
Myung Hoon KWON ; Joon Hwa NOH ; Lee Chul YANG ; Joon BAE ; Young Bong JEONG ; Sang Ik KIM
Korean Journal of Urology 2002;43(3):246-249
Retroperitoneal fibrosis, although benign, has a malignant course due to an encasement and obstruction of the retroperitoneal structures, particularly the urinary system. The most common treatment is often a surgical exploration followed by urologic intervention. However, steroid or azathioprine therapy has been advocated, with varying results and major side-effects. Recently, the successful medical therapy in patients with an early stage and low malignant potential has been reported. Here we report a male patient who underwent successful treatment of an idiopathic retroperitoneal fibrosis with tamoxifen and prednisolone.
Azathioprine
;
Humans
;
Male
;
Prednisolone
;
Retroperitoneal Fibrosis*
;
Tamoxifen
;
Ureter
9.A Case of Retroperitoneal Fibrosis Associated with Stomach Cancer.
Chang Sup HAN ; Sung Young LEE ; Chee Ho PARK ; Sung Hyup CHOI
Korean Journal of Urology 1987;28(3):455-458
We report a case of retroperitoneal fibrosis of uncertain cause, in which surgical ureterolysis could be established. The initial symptoms of patient were right flank dull pain and low abdominal discomfortness. At the multiple biopsy during ureterolysis, no neoplastic cell could be seen. After one month of discharge, advanced stomach cancer was found during evaluation of dysphasia and indigestion which appeared after discharge. So, the patient was placed on the conservative treatment after ureterolysis due to advanced stomach cancer.
Aphasia
;
Biopsy
;
Dyspepsia
;
Humans
;
Retroperitoneal Fibrosis*
;
Stomach Neoplasms*
;
Stomach*
10.Rapidly resolved IgG4-related retroperitoneal fibrosis after steroid pulse therapy.
Soomin JEUNG ; Hyosang KIM ; Yuri SEO ; Hee Young YOON ; Nah Kyum LEE ; Shinhee PARK ; Bomi SEO ; Su Yeon PARK ; Su Kil PARK
Yeungnam University Journal of Medicine 2016;33(1):40-43
Retroperitoneal fibrosis (RF) is a disorder characterized by the presence of a retroperitoneal mass and concurrent systemic inflammation. Some cases of RF are recognized as belonging to the spectrum of immunoglobulin G4-related disease (IgG4-RD). Glucocorticoids are highly effective for treatment of retroperitoneal fibrosis, although the optimal dose and duration of therapy have not been established. An initial dose of prednisone (40-60 mg) daily is usually administered with a tapering scheme. We report on a 55-year-old man diagnosed with IgG4-related RF and successfully treated with a 3-day course of daily 250 mg (4 mg/kg) intravenous methylprednisolone, which resulted in the prompt resolution of urinary obstruction and systemic symptoms.
Glucocorticoids
;
Humans
;
Immunoglobulins
;
Inflammation
;
Methylprednisolone
;
Middle Aged
;
Prednisone
;
Retroperitoneal Fibrosis*